| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/05/2014 | CA2519092C Branched water-soluble polymers and their conjugates |
| 08/05/2014 | CA2507115C Treatment of mammalian reaction to ige interactions |
| 08/05/2014 | CA2486649C Fusion protein comprising angiopoietin receptor-binding and a multimerization domain |
| 08/05/2014 | CA2461351C Mutated anti-cd22 antibodies with increased affinity to cd22-expressing leukemia cells |
| 08/05/2014 | CA2457140C Beta-amyloid-analogue - t-cell epitope vaccine |
| 08/05/2014 | CA2430972C Fibrin fragments for treating inflammation |
| 07/31/2014 | WO2014117164A2 Airway device with tongue-engaging member |
| 07/31/2014 | WO2014117155A1 Placenta growth factor in treating duchenne muscular dystrophy |
| 07/31/2014 | WO2014116982A2 Methods of modulating gabaergic inhibitory synapse formation and function |
| 07/31/2014 | WO2014116981A1 Follistatin in treating duchenne muscular dystrophy |
| 07/31/2014 | WO2014116958A1 Compositions and methods involving endogenous retrovirus proteins |
| 07/31/2014 | WO2014116871A1 Methods and pharmaceutical compositions for treating celiac disease and gluten intolerance |
| 07/31/2014 | WO2014116786A1 Use of human chorionic gonadotropin to treat cerebral palsy and/or its co-morbidities |
| 07/31/2014 | WO2014116753A1 N-terminal truncated insulin analogues |
| 07/31/2014 | WO2014116706A1 Tissue plasminogen activator antibodies and methods of use thereof |
| 07/31/2014 | WO2014116275A1 INHIBITION OF TISSUE FACTOR PATHWAY INHIBITOR WITH FACTOR Xa DERIVATIVES |
| 07/31/2014 | WO2014116187A1 Crosslinked peptide hydrogels |
| 07/31/2014 | WO2014115033A2 Methods of treating cardiovascular indications |
| 07/31/2014 | WO2014114787A1 Apolipoprotein a-i derived peptides for treatment of hyperglycaemia |
| 07/31/2014 | WO2014114719A1 Hemostatic compositions |
| 07/31/2014 | WO2014114706A1 Compositions containing chondroitin sulphate, proteolytic enzymes and sulphydryl compounds for improving the bioavailability of chondroitin sulphate |
| 07/31/2014 | WO2014114300A1 Novel disease-marker |
| 07/31/2014 | WO2014113878A1 Method of treating fibrosis in skeletal muscle tissue |
| 07/31/2014 | WO2014113875A1 Use of protectin dx for the stimulation of muscular il-6 secretion |
| 07/31/2014 | WO2014106116A3 Therapeutic compositions comprising antibodies |
| 07/31/2014 | WO2014083040A3 Progranulin as marker for autoimmune disorders |
| 07/31/2014 | WO2014078734A3 Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods |
| 07/31/2014 | WO2014078731A3 Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods |
| 07/31/2014 | WO2014041500A3 Double mutant coagulation factor viii and methods thereof |
| 07/31/2014 | WO2014008465A3 Potentiation of antibiotic treatment with a protein-lipid complex |
| 07/31/2014 | US20140215644 Soluble protein cd5 or cd6 for the treatment of cancer or tumor or for use as an adjuvant |
| 07/31/2014 | US20140213990 Compositions and methods for treating surface wounds |
| 07/31/2014 | US20140213984 Octreotide injection |
| 07/31/2014 | US20140213635 Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure |
| 07/31/2014 | US20140213604 Protein kinase c as a target for the treatment of respiratory syncytial virus |
| 07/31/2014 | US20140213534 Intestinal hyperpermeability and prevention of systemic disease |
| 07/31/2014 | US20140213533 Methods to detect, treat and prevent acute cellular rejection in kidney allografts |
| 07/31/2014 | US20140213532 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 07/31/2014 | US20140213530 Methods for treatment of cancer by targeting sirt5 |
| 07/31/2014 | US20140213529 Pseudomonas exotoxin a with less immunogenic b cell epitopes |
| 07/31/2014 | US20140213526 Small survival-promoting/immunomodulatory peptide for treatment of brain damage, neurodegenerative disorders, and inflammatory disorders |
| 07/31/2014 | US20140213525 Corneal stiffening for treating astigmatism |
| 07/31/2014 | US20140213524 Composition for regeneration of cartilage |
| 07/31/2014 | US20140213520 Methods of treating cardiovascular indications |
| 07/31/2014 | US20140213519 Methods of treating cardiovascular indications |
| 07/31/2014 | US20140213518 Methods of enhancing functioning of the large intestine |
| 07/31/2014 | US20140213517 Thermoresponsive, Biodegradable, Elastomeric Material and Uses Therefor |
| 07/31/2014 | US20140213516 Therapeutic agents comprising elastic peptides |
| 07/31/2014 | US20140213513 Exendin-4 Derivatives as dual GLP1/GIP or trigonal GLP1/GIP/Glucagon Agonists |
| 07/31/2014 | US20140213512 Method of Treating or Ameliorating Type 1 Diabetes Using FGF21 |
| 07/31/2014 | US20140213511 Compositions and methods of use for treating metabolic disorders |
| 07/31/2014 | US20140213510 Use of pleitrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
| 07/31/2014 | US20140213506 Thymosin alpha peptide for preventing, reducing the severity of, and treating infection |
| 07/31/2014 | US20140213503 Solid composition |
| 07/31/2014 | US20140212946 Non-natural ribonuclease conjugates as cytotoxic agents |
| 07/31/2014 | US20140212510 Capcna peptide therapeutics for cancer |
| 07/31/2014 | US20140212504 Phospholipid-based powders for drug delivery |
| 07/31/2014 | US20140212492 Oral Enzyme Compositions for Intestinal Delivery |
| 07/31/2014 | US20140212477 Hemoglobin-containing liposome and method for producing same |
| 07/31/2014 | US20140212475 Anti-cancer compositions and methods |
| 07/31/2014 | US20140212440 Conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereof |
| 07/31/2014 | US20140212430 Multiple-variable dose regimen for treating tnfalpha-related disorders |
| 07/31/2014 | US20140212420 Soluble tumor necrosis factor receptor treatment of medical disorders |
| 07/31/2014 | US20140212419 Ester-based insulin prodrugs |
| 07/31/2014 | US20140212407 Treatment of obesity |
| 07/31/2014 | US20140212405 Fibrinolytic/Proteolytic Treatment of Myofacial and Neuropathic Pain and Related Conditions |
| 07/31/2014 | US20140212404 Compositions and Methods for Treating Injuries to the Visual System of a Human |
| 07/31/2014 | US20140212403 Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria |
| 07/31/2014 | US20140212393 Compositions and Methods for the Treatment of Lysosomal Storage Disorders |
| 07/31/2014 | US20140212384 Therapeutic Methods |
| 07/31/2014 | US20140212381 Macrocycles |
| 07/31/2014 | US20140210117 Pharmaceutical compositions of dispersions of drug and neutral polymers |
| 07/30/2014 | EP2759593A1 Novel ADAMTS-13 mutant |
| 07/30/2014 | EP2759305A1 Hemostatic compositions |
| 07/30/2014 | EP2759304A1 Fungal immunomodulatory protein for use in the treatment of cancer |
| 07/30/2014 | EP2759303A2 Use for glycolipoprotein gintonin, isolated and identified from ginseng, as a natural medicinal-plant-derived ligand |
| 07/30/2014 | EP2759302A2 4F-benzoyl-TN14003 combined with rituximab for use in the treatment of a tumour |
| 07/30/2014 | EP2758774A1 Method for monitoring, diagnosis and/or prognosis of acute kidney injury in early stage |
| 07/30/2014 | EP2758426A1 Novel glucagon analogues |
| 07/30/2014 | EP2758423A2 Peptides having protective effect towards the inflammatory activity of peptide 31-43 of a-gliadin in celiac disease |
| 07/30/2014 | EP2758082A2 Methods of treating fatty liver disease with helminth-derived glycan-containing compounds |
| 07/30/2014 | EP2758080A1 Cancer immunotherapy |
| 07/30/2014 | EP2758076A1 Combination therapy using immunoglobulin and c1-inhibitor |
| 07/30/2014 | EP2758070A1 Methods and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase |
| 07/30/2014 | EP2758069A2 Method to predict the presence of inflammation or itaconic acid, irg1 and/or protein irg1 in a subject and pharmaceutical composition for treating or preventing inflammation |
| 07/30/2014 | EP2758068A1 Yersinia outer protein m (yopm) in the treatment of psoriasis |
| 07/30/2014 | EP2758067A1 Romidepsin and 5 - azacitidine for use in treating lymphoma |
| 07/30/2014 | EP2758066A1 Tripeptide kdpt for antiapoptotic treatment |
| 07/30/2014 | EP2758065A2 Alpha1-proteinase inhibitor for delaying the onset or progression of pulmonary exacerbations |
| 07/30/2014 | CN203736556U 生产氢分子的微胶囊构造 Microcapsule structure produced hydrogen molecules |
| 07/30/2014 | CN1976715B 与腹部疾病有关的表位 Abdominal disease epitope |
| 07/30/2014 | CN103958676A 重组人naglu蛋白质及其用途 Recombinant human protein and its use naglu |
| 07/30/2014 | CN103957944A 用含蠕虫衍生的聚糖的化合物治疗脂肪肝病的方法 Compounds containing a worm-derived glycans treatment of fatty liver |
| 07/30/2014 | CN103957939A 癌症免疫治疗 Cancer immunotherapy |
| 07/30/2014 | CN103957936A 用于调控电压门控钙通道功能的方法和组合物 Methods for modulating voltage-gated calcium channel function and composition |
| 07/30/2014 | CN103957935A 抗cgrp或抗cgrp-r抗体或抗体片段用于治疗或预防慢性和急性形式的腹泻的用途 Or anti-anti cgrp use cgrp-r antibody or antibody fragment for the treatment or prevention of diarrhea, chronic and acute forms of |
| 07/30/2014 | CN103957929A 具有溶菌酶活性的多肽和编码所述多肽的多核苷酸 Polypeptide having lysozyme activity and polynucleotides encoding the polypeptides |
| 07/30/2014 | CN103957928A 乳铁蛋白和白质 Lactoferrin and white matter |
| 07/30/2014 | CN103957927A 呈现糖皮质激素受体活性的胰高血糖素超家族肽 Rendering of glucocorticoid receptor activity of the glucagon superfamily peptide |
| 07/30/2014 | CN103957926A 具有增强的作用持续时间和降低的免疫原性的工程改造的多肽 Polypeptide has enhanced the role of duration and reduced immunogenicity of engineered |